Delivery Order SPE2DB22D9225-SPE2DB24FR8EH
Award Date 2/2/24
Potential Completion Date 2/26/24
Potential Value $4.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML for a potential value of $1,547.40. This order is part of a larger indefinite delivery vehicle contract, 4600082013 under the DLA's SPE2DB program, valued up to $4,999,999 through 2025. Through this contract, DMS Pharmaceutical Group supplies a broad range of pharmaceutical items to military health facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML syringes and has a performance period through May 2, 2024. This award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, valued at up to $4,999,999 through 2025. Under this broader contract vehicle, DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, number SPE2DB24FZB70, to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML. The $18,568.80 order has an ultimate completion date of April 16, 2024. This delivery order is part of a larger indefinite delivery contract, number SPE2DB22D9143, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDC enables DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Xolair 150 mg/mL syringes. The contract, valued at $9,284.40, has an ultimate completion date of April 23, 2024. This delivery order falls under DMS Pharmaceutical Group's existing indefinite delivery contract, SPE2DB22D9362, with the DLA worth up to $4,999,999 through the end of 2025. This larger contract enables the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML. The $10,831.80 contract has a completion date of December 29, 2023 and does not have a set-aside designation. DMS Pharmaceutical Group is an experienced federal contractor that holds a $4,999,999 indefinite delivery contract with DLA to deliver a wide range of pharmaceutical products to military health...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/ml syringes. The award, valued at $11,605.50, has an ultimate completion date of April 16, 2024. This order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through 2025. Under this IDV, DMS Pharmaceutical Group...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/mL syringes. The contract has a ceiling value of $3,094.80 and a period of performance through July 29, 2024. This contract was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which supports the recurring pharmaceutical supply...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGE/ML. The firm fixed-price contract has a potential value of $9,284.40 and a completion date of March 27, 2024. This award is made under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency's SPE2DB program, which has a ceiling of up to $4,999,999...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $77,370.00, is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML to the DLA. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025. The IDV...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,642.20, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialty medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the...